Important Notice for PepGen Inc. Shareholders
Attention all shareholders of PepGen Inc., trading under NASDAQ: PEPG! If you purchased shares between March 7, 2024, and March 3, 2025, significant news is unfolding that you need to be aware of. The Gross Law Firm has announced a class action lawsuit against the company due to allegations of misleading statements and undisclosed issues affecting its lead product candidate, PGN-EDO51.
Background of the Class Action
The allegations against PepGen indicate that the company's messaging was not only overly optimistic but also potentially misleading regarding the safety and effectiveness of PGN-EDO51. Investors were informed that the drug was performing well, yet reports suggest that it was, in fact, less effective than communicated. This discrepancy places investors at risk, as many may have made financial decisions based on inaccurate information.
In particular, the lawsuit alleges that:
1.
Ineffective Product: PGN-EDO51 was portrayed as more effective and safe than it truly was.
2.
Deficient Study: The phase two CONNECT2 study may have had significant deficiencies, impacting its eligibility for FDA approval.
3.
Misleading Prospects: Due to the aforementioned issues, PepGen's potential for success and its prospects for the drug were exaggerated.
4.
False Public Statements: The public statements made by PepGen were claimed to be misleading and factually incorrect.
Key Dates to Remember
Shareholders must take note of the upcoming deadline to register for participation in the class action.
August 8, 2025 is the cutoff date for those looking to join the lawsuit and potentially become lead plaintiffs. The recommendation is to act swiftly to secure your position, as it is crucial not to miss this opportunity.
Next Steps for Shareholders
Upon registering as a shareholder who acquired PEPG shares within the specified timeframe, you will have access to portfolio monitoring software. This tool will provide regular updates regarding the status of the case, ensuring you stay informed. Notably, there is no financial obligation to participate in the class action, making it a risk-free opportunity for shareholders.
Why Choose The Gross Law Firm?
The Gross Law Firm is well-known within the realm of class action lawsuits and champions the rights of investors. Their commitment to protecting shareholders from corporate misconduct is evident in their approach to these cases. They prioritize transparency and integrity, ensuring that those affected by misleading practices have a pathway to seek justice and compensation.
If you believe you qualify for this case or want to learn more about the class action against PepGen, please register your information at the Gross Law Firm's official portal
here. You have rights as an investor and it is the firm’s mission to advocate for those who have been misled by corporate deception.
For further inquiries or to gain more insight on potential recovery options, you can also reach out directly to the Gross Law Firm:
- - Email: [email protected]
- - Phone: (646) 453-8903
- - Address: 15 West 38th Street, 12th Floor, New York, NY 10018.
Don’t hesitate to take action now – your rights and investments deserve to be protected.